M&T Bank
CRL icon

M&T Bank’s Charles River Laboratories CRL Stock Holding History

M&T Bank’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$390K Sell
2,263
-164
-7% -$30.4K ﹤0.01% 1235
2025
Q4 		$484K Buy
2,427
+591
+32% +$107K ﹤0.01% 1140
2025
Q3 		$287K Sell
1,836
-695
-27% -$110K ﹤0.01% 1229
2025
Q2 		$384K Buy
2,531
+544
+27% +$72.5K ﹤0.01% 1174
2025
Q1 		$299K Sell
1,987
-259
-12% -$43.4K ﹤0.01% 1267
2024
Q4 		$415K Buy
2,246
+245
+12% +$47.2K ﹤0.01% 1241
2024
Q3 		$394K Buy
2,001
+66
+3% +$13.7K ﹤0.01% 1248
2024
Q2 		$400K Sell
1,935
-278
-13% -$63K ﹤0.01% 1202
2024
Q1 		$600K Buy
2,213
+294
+15% +$70.2K ﹤0.01% 1070
2023
Q4 		$454K Sell
1,919
-157
-8% -$30.9K ﹤0.01% 1156
2023
Q3 		$407K Buy
2,076
+66
+3% +$13.6K ﹤0.01% 1169
2023
Q2 		$423K Sell
2,010
-60
-3% -$11.9K ﹤0.01% 1190
2023
Q1 		$418K Sell
2,070
-62
-3% -$14.1K ﹤0.01% 1174
2022
Q4 		$464K Buy
2,132
+90
+4% +$19.7K ﹤0.01% 1134
2022
Q3 		$402K Sell
2,042
-642
-24% -$139K ﹤0.01% 1173
2022
Q2 		$478K Buy
2,684
+794
+42% +$194K ﹤0.01% 1029
2022
Q1 		$535K Buy
1,890
+354
+23% +$109K ﹤0.01% 960
2021
Q4 		$578K Buy
1,536
+109
+8% +$42.3K ﹤0.01% 962
2021
Q3 		$590K Sell
1,427
-210
-13% -$87.2K ﹤0.01% 934
2021
Q2 		$605K Sell
1,637
-182
-10% -$60.8K ﹤0.01% 939
2021
Q1 		$527K Sell
1,819
-373
-17% -$104K ﹤0.01% 973
2020
Q4 		$547K Sell
2,192
-166
-7% -$39.5K ﹤0.01% 1002
2020
Q3 		$534K Sell
2,358
-84
-3% -$17.4K ﹤0.01% 950
2020
Q2 		$427K Sell
2,442
-451
-16% -$72K ﹤0.01% 1007
2020
Q1 		$365K Buy
2,893
+8
+0.3% +$1.2K ﹤0.01% 1027
2019
Q4 		$440K Buy
2,885
+216
+8% +$29.9K ﹤0.01% 908
2019
Q3 		$353K Sell
2,669
-24
-0.9% -$3.22K ﹤0.01% 1108
2019
Q2 		$381K Sell
2,693
-937
-26% -$127K ﹤0.01% 1110
2019
Q1 		$527K Sell
3,630
-362
-9% -$47.6K ﹤0.01% 933
2018
Q4 		$453K Sell
3,992
-16
-0.4% -$2K ﹤0.01% 946
2018
Q3 		$539K Buy
4,008
+304
+8% +$37.5K ﹤0.01% 974
2018
Q2 		$416K Buy
3,704
+149
+4% +$16.1K ﹤0.01% 1092
2018
Q1 		$379K Sell
3,555
-26
-0.7% -$2.8K ﹤0.01% 1119
2017
Q4 		$392K Sell
3,581
-74
-2% -$8.05K ﹤0.01% 1120
2017
Q3 		$395K Sell
3,655
-703
-16% -$72.2K ﹤0.01% 1094
2017
Q2 		$441K Buy
4,358
+76
+2% +$7K ﹤0.01% 1023
2017
Q1 		$386K Sell
4,282
-11
-0.3% -$934 ﹤0.01% 1113
2016
Q4 		$327K Sell
4,293
-28
-0.6% -$2.13K ﹤0.01% 1237
2016
Q3 		$359K Sell
4,321
-3,351
-44% -$281K ﹤0.01% 1192
2016
Q2 		$632K Buy
7,672
+2,147
+39% +$177K ﹤0.01% 939
2016
Q1 		$419K Sell
5,525
-1,011
-15% -$74.8K ﹤0.01% 1127
2015
Q4 		$526K Buy
+6,536
New +$471K ﹤0.01% 1047
2015
Q2 		– Sell
-2,769
Closed -$219K – 2111
2015
Q1 		$219K Buy
+2,769
New +$204K ﹤0.01% 1689
2014
Q4 		– Sell
-3,586
Closed -$215K – 2151
2014
Q3 		$215K Buy
3,586
+3,549
+9,592% +$203K ﹤0.01% 1837
2014
Q2 		$2K Sell
37
-23
-38% -$1.26K ﹤0.01% 1041
2014
Q1 		$4K Buy
+60
New +$3.5K ﹤0.01% 1016

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

M&T Bank's CRL Position: Q1 2026 in Review

M&T Bank reduced its Charles River Laboratories (CRL) stake by 6.8% in Q1 2026, selling an estimated $30.4K and leaving 2,263 shares worth $390K. The position accounts for ﹤0.01% of the portfolio, ranked #1235.

M&T Bank first reported a position in CRL in Q1 2014 and has held it in 46 quarters since. The position peaked at $632K in Q2 2016. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • M&T Bank held 2,263 shares of Charles River Laboratories worth $390K as of Q1 2026.
  • M&T Bank sold 164 Charles River Laboratories shares in Q1 2026, an estimated $30.4K.
  • Charles River Laboratories made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1235 holding.
  • M&T Bank first reported a position in Charles River Laboratories in Q1 2014 and has held it in 46 quarters since.
  • M&T Bank's Charles River Laboratories position peaked at $632K in Q2 2016.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.